{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:45:33Z","timestamp":1785804333245,"version":"3.56.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Zonmw","doi-asserted-by":"publisher","award":["01142042330003"],"award-info":[{"award-number":["01142042330003"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMW","doi-asserted-by":"publisher","award":["01142042330004"],"award-info":[{"award-number":["01142042330004"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMW","doi-asserted-by":"publisher","award":["01142042330006"],"award-info":[{"award-number":["01142042330006"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02427-0","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:58:12Z","timestamp":1785797892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the NO\u2013cGMP axis in age-related vascular dysfunction: a systematic review and meta-analysis of preclinical animal studies"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5710-3057","authenticated-orcid":false,"given":"Soroush Mohammadi","family":"Jouabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keivan","family":"Golshiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan Ataei","family":"Ataabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youri","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forough","family":"Kheiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hosein","family":"Khajehali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H. Jan","family":"Danser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wichor M.","family":"Bramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton J. M.","family":"Roks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlijn R.","family":"Hooijmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"12","key":"2427_CR1","first-page":"1839","volume":"39","author":"SM Jouabadi","year":"2023","unstructured":"Jouabadi SM, Ataabadi EA, Golshiri K, Bos D, Stricker BHC, Danser AHJ, et al. Clinical impact and mechanisms of nonatherosclerotic vascular aging: the new kid to be blocked. Can J Cardiol. 2023;39(12):1839\u201358.","journal-title":"Can J Cardiol"},{"key":"2427_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042169","author":"AM Sheikh","year":"2024","unstructured":"Sheikh AM, Yano S, Tabassum S, Nagai A. The role of the vascular system in degenerative diseases: mechanisms and implications. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25042169.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2427_CR3","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/joim.12296","volume":"276","author":"L Badimon","year":"2014","unstructured":"Badimon L, Vilahur G. Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med. 2014;276(6):618\u201332.","journal-title":"J Intern Med"},{"issue":"2","key":"2427_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243\u201378.","journal-title":"Cell"},{"issue":"9","key":"2427_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1042\/CS20100476","volume":"120","author":"DR Seals","year":"2011","unstructured":"Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothelial function in humans. Clin Sci (Lond). 2011;120(9):357\u201375.","journal-title":"Clin Sci (Lond)"},{"issue":"12","key":"2427_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s11883-024-01241-3","volume":"26","author":"A d\u2019Aiello","year":"2024","unstructured":"d\u2019Aiello A, Filomia S, Brecciaroli M, Sanna T, Pedicino D, Liuzzo G. Targeting inflammatory pathways in atherosclerosis: exploring new opportunities for treatment. Curr Atheroscler Rep. 2024;26(12):707\u201319.","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"2427_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-011-0219-7","volume":"14","author":"UK Sampson","year":"2012","unstructured":"Sampson UK, Fazio S, Linton MF. Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges. Curr Atheroscler Rep. 2012;14(1):1\u201310.","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"2427_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/CIRCRESAHA.116.310527","volume":"120","author":"PM Ridker","year":"2017","unstructured":"Ridker PM. How common is residual inflammatory risk? Circ Res. 2017;120(4):617\u20139.","journal-title":"Circ Res"},{"key":"2427_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf370","author":"S Mohammadi Jouabadi","year":"2025","unstructured":"Mohammadi Jouabadi S, Claringbould A, Danser AHJ, Stricker BH, Kavousi M, Roks AJM, et al. High-sensitivity C-reactive protein mediates age-related vascular dysfunction: the Rotterdam study. Eur J Prev Cardiol. 2025. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf370.","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"2427_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/bcpt.13319","volume":"127","author":"K Golshiri","year":"2020","unstructured":"Golshiri K, Ataei Ataabadi E, Portilla Fernandez EC, Jan Danser AH, Roks AJM. The importance of the nitric oxide-cGMP pathway in age-related cardiovascular disease: focus on phosphodiesterase-1 and soluble guanylate cyclase. Basic Clin Pharmacol Toxicol. 2020;127(2):67\u201380.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"2427_CR11","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/HYPERTENSIONAHA.120.15856","volume":"76","author":"E Ataei Ataabadi","year":"2020","unstructured":"Ataei Ataabadi E, Golshiri K, J\u00fcttner A, Krenning G, Danser AHJ, Roks AJM. Nitric oxide-cGMP signaling in hypertension. Hypertension. 2020;76(4):1055\u201368.","journal-title":"Hypertension"},{"issue":"3","key":"2427_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmr.2025.100042","volume":"77","author":"MP Kelly","year":"2025","unstructured":"Kelly MP, Nikolaev VO, Gobejishvili L, Lugnier C, Hesslinger C, Nickolaus P, et al. Cyclic nucleotide phosphodiesterases as drug targets. Pharmacol Rev. 2025;77(3):100042.","journal-title":"Pharmacol Rev"},{"issue":"12","key":"2427_CR13","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1089\/ars.2021.0031","volume":"35","author":"EP Tracy","year":"2021","unstructured":"Tracy EP, Hughes W, Beare JE, Rowe G, Beyer A, LeBlanc AJ. Aging-induced impairment of vascular function: mitochondrial redox contributions and physiological\/clinical implications. Antioxid Redox Signal. 2021;35(12):974\u20131015.","journal-title":"Antioxid Redox Signal"},{"key":"2427_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ani9100754","author":"RC Hubrecht","year":"2019","unstructured":"Hubrecht RC, Carter E. The 3Rs and humane experimental technique: implementing change. Animals (Basel). 2019. https:\/\/doi.org\/10.3390\/ani9100754.","journal-title":"Animals (Basel)"},{"issue":"2","key":"2427_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/02763869.2019.1588072","volume":"38","author":"JH Schiavo","year":"2019","unstructured":"Schiavo JH. PROSPERO: an international register of systematic review protocols. Med Ref Serv Q. 2019;38(2):171\u201380.","journal-title":"Med Ref Serv Q"},{"key":"2427_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"2427_CR17","doi-asserted-by":"publisher","DOI":"10.1556\/1661.2025.00104","author":"F Sorond","year":"2026","unstructured":"Sorond F, Jea A, Hegyi P, Yabluchanskiy A. Guidelines for meta-analyses in pharmacology and biomedical research: a consensus framework for design, conduct, and reporting. Advances in Translational Research. 2026. https:\/\/doi.org\/10.1556\/1661.2025.00104.","journal-title":"Advances in Translational Research"},{"issue":"1","key":"2427_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"key":"2427_CR19","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment, 2026. Oslo; 2026."},{"issue":"1","key":"2427_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14(1):43.","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"2427_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1\u201348.","journal-title":"J Stat Softw"},{"key":"2427_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.893774","volume":"9","author":"MC Guido","year":"2022","unstructured":"Guido MC, Lopes NdM, Albuquerque CI, Tavares ER, Jensen L, Carvalho PdO, et al. Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome. Front Cardiovasc Med. 2022;9:893774.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2427_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10787-022-01104-w","volume":"31","author":"ST Rafik","year":"2023","unstructured":"Rafik ST, Zeitoun TM, Shalaby TI, Barakat MK, Ismail CA. Methotrexate conjugated gold nanoparticles improve rheumatoid vascular dysfunction in rat adjuvant-induced arthritis: gold revival. Inflammopharmacology. 2023;31(1):321\u201335.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"2427_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13075-015-0790-3","volume":"17","author":"A Virdis","year":"2015","unstructured":"Virdis A, Tani C, Duranti E, Vagnani S, Carli L, K\u00fchl AA, et al. Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus. Arthritis Res Ther. 2015;17(1):277.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2427_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/HYPERTENSIONAHA.114.03587","volume":"64","author":"M G\u00f3mez-Guzm\u00e1n","year":"2014","unstructured":"G\u00f3mez-Guzm\u00e1n M, Jim\u00e9nez R, Romero M, S\u00e1nchez M, Zarzuelo MJ, G\u00f3mez-Morales M, et al. Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus. Hypertension. 2014;64(2):330\u20137.","journal-title":"Hypertension"},{"issue":"1-3","key":"2427_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejphar.2005.12.003","volume":"531","author":"N Shukla","year":"2006","unstructured":"Shukla N, Koupparis A, Jones RAW, Angelini GD, Persad R, Jeremy JY. Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit. Eur J Pharmacol. 2006;531(1\u20133):201\u20138.","journal-title":"Eur J Pharmacol"},{"issue":"13","key":"2427_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134667","volume":"21","author":"K Golshiri","year":"2020","unstructured":"Golshiri K, Ataei Ataabadi E, Brandt R, van der Pluijm I, de Vries R, Danser AHJ, et al. Chronic sildenafil treatment improves vasomotor function in a mouse model of accelerated aging. Int J Mol Sci. 2020;21(13):4667.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2427_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/jpet.121.000628","volume":"378","author":"K Golshiri","year":"2021","unstructured":"Golshiri K, Ataei Ataabadi E, Rubio-Beltran E, Dutheil S, Yao W, Snyder GL, et al. Selective phosphodiesterase 1 inhibition ameliorates vascular function, reduces inflammatory response, and lowers blood pressure in aging animals. J Pharmacol Exp Ther. 2021;378(2):173\u201383.","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"2427_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.818355","volume":"31","author":"K Golshiri","year":"2022","unstructured":"Golshiri K, Ataabadi EA, J\u00fcttner AA, Snyder GL, Davis RE, Lin A, Zhang L, de Vries R, Garrelds IM, Leijten FP, Danser AJ. The effects of acute and chronic selective phosphodiesterase 1 inhibition on smooth muscle cell-associated aging features. Frontiers in Pharmacology. 2022Jan;31(12): 818355.","journal-title":"Frontiers in Pharmacology."},{"key":"2427_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejphar.2018.01.019","volume":"822","author":"HS Moreira","year":"2018","unstructured":"Moreira HS, Lima-Leal GA, Santos-Rocha J, Gomes-Pereira L, Duarte GP, Xavier FE. Phosphodiesterase-3 inhibitor cilostazol reverses endothelial dysfunction with ageing in rat mesenteric resistance arteries. Eur J Pharmacol. 2018;822:59\u201368.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"2427_CR31","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1161\/01.STR.0000158923.19956.73","volume":"36","author":"L Zhang","year":"2005","unstructured":"Zhang L, Zhang RL, Wang Y, Zhang C, Zhang ZG, Meng H, et al. Functional recovery in aged and young rats after embolic stroke. Stroke. 2005;36(4):847\u201352.","journal-title":"Stroke"},{"issue":"9","key":"2427_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13683","volume":"21","author":"E AtaeiAtaabadi","year":"2022","unstructured":"AtaeiAtaabadi E, Golshiri K, J\u00fcttner AA, de Vries R, Van den Berg-Garrelds I, Nagtzaam NMA, et al. Soluble guanylate cyclase activator BAY 54\u20136544 improves vasomotor function and survival in an accelerated ageing mouse model. Aging Cell. 2022;21(9):e13683.","journal-title":"Aging Cell"},{"issue":"1","key":"2427_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/CIRCRESAHA.122.322033","volume":"132","author":"N Foussard","year":"2023","unstructured":"Foussard N, Rouault P, Cornuault L, Reynaud A, Buys ES, Chapouly C, et al. Praliciguat promotes ischemic leg reperfusion in leptin receptor-deficient mice. Circ Res. 2023;132(1):34\u201348.","journal-title":"Circ Res"},{"issue":"5","key":"2427_CR34","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1165\/rcmb.2017-0292OC","volume":"58","author":"KP Potoka","year":"2018","unstructured":"Potoka KP, Wood KC, Baust JJ, Bueno M, Hahn SA, Vanderpool RR, et al. Nitric oxide\u2013independent soluble guanylate cyclase activation improves vascular function and cardiac remodeling in sickle cell disease. Am J Respir Cell Mol Biol. 2018;58(5):636\u201347.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"8","key":"2427_CR35","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/CIRCRESAHA.111.246876","volume":"110","author":"BJ North","year":"2012","unstructured":"North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;110(8):1097\u2013108.","journal-title":"Circ Res"},{"issue":"7","key":"2427_CR36","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2507266","volume":"25","author":"N Pilz","year":"2024","unstructured":"Pilz N, Heinz V, Ax T, Fesseler L, Patzak A, Bothe TL. Pulse wave velocity: methodology, clinical applications, and interplay with heart rate variability. Rev Cardiovasc Med. 2024;25(7):266.","journal-title":"Rev Cardiovasc Med"},{"issue":"7","key":"2427_CR37","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/diagnostics16071025","volume":"16","author":"E Silva","year":"2026","unstructured":"Silva E, Nicolai M, Monteiro RL. Optimizing in vivo perfusion assessment by laser Doppler flowmetry\u2014effects of probe geometry and signal normalization. Diagnostics. 2026;16(7):1025.","journal-title":"Diagnostics"},{"issue":"2","key":"2427_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.arr.2009.07.002","volume":"9","author":"MD Herrera","year":"2010","unstructured":"Herrera MD, Mingorance C, Rodr\u00edguez-Rodr\u00edguez R, Alvarez de Sotomayor M. Endothelial dysfunction and aging: an update. Ageing Res Rev. 2010;9(2):142\u201352.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"2427_CR39","doi-asserted-by":"publisher","first-page":"H1016","DOI":"10.1152\/ajpheart.00779.2004","volume":"288","author":"E Vila","year":"2005","unstructured":"Vila E, Salaices M. Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol. 2005;288(3):H1016\u201321.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"2427_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cardiores.2004.06.020","volume":"64","author":"BR Clapp","year":"2004","unstructured":"Clapp BR, Hingorani AD, Kharbanda RK, Mohamed-Ali V, Stephens JW, Vallance P, et al. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res. 2004;64(1):172\u20138.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"2427_CR41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00395-008-0733-0","volume":"103","author":"C Zhang","year":"2008","unstructured":"Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol. 2008;103(5):398\u2013406.","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"2427_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41569-022-00739-0","volume":"20","author":"SI Bloom","year":"2023","unstructured":"Bloom SI, Islam MT, Lesniewski LA, Donato AJ. Mechanisms and consequences of endothelial cell senescence. Nat Rev Cardiol. 2023;20(1):38\u201351.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"2427_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-022-02930-7","volume":"24","author":"G Cafaro","year":"2022","unstructured":"Cafaro G, Petito E, Bistoni O, Falcinelli E, Cipriani S, Borghi MC, et al. Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment. Arthritis Res Ther. 2022;24(1):236.","journal-title":"Arthritis Res Ther"},{"key":"2427_CR44","doi-asserted-by":"publisher","unstructured":"Mangoni AA, Woodman RJ, Piga M, Cauli A, Fedele AL, Gremese E, et al. Patterns of anti-inflammatory and immunomodulating drug usage and microvascular endothelial function in rheumatoid arthritis. Front. Cardiovasc. Med. 2021;8:681327. https:\/\/doi.org\/10.3389\/fcvm.2021.681327.","DOI":"10.3389\/fcvm.2021.681327"},{"key":"2427_CR45","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.s523939","author":"O Garmish","year":"2025","unstructured":"Garmish O, Smiyan S, Hladkykh F, Koshak B, Komorovsky R. The effects of disease-modifying antirheumatic drugs on cardiovascular risk in inflammatory joint diseases: current evidence and uncertainties. Vasc Health Risk Manag. 2025. https:\/\/doi.org\/10.2147\/vhrm.s523939.","journal-title":"Vasc Health Risk Manag"},{"issue":"8","key":"2427_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.812631","volume":"3","author":"Y Baoqi","year":"2022","unstructured":"Baoqi Y, Dan M, Xingxing Z, Xueqing Z, Yajing W, Ke X, Liyun Z. Effect of anti-rheumatic drugs on cardiovascular disease events in rheumatoid arthritis. Frontiers in cardiovascular medicine. 2022Feb;3(8): 812631.","journal-title":"Frontiers in cardiovascular medicine."},{"issue":"1","key":"2427_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-020-00983-9","volume":"21","author":"A Udupa","year":"2021","unstructured":"Udupa A, Leverenz D, Balevic SJ, Sadun RE, Tarrant TK, Rogers JL. Hydroxychloroquine and COVID-19: a rheumatologist\u2019s take on the lessons learned. Curr Allergy Asthma Rep. 2021;21(1):5.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"2427_CR48","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/FJC.0b013e318157f72d","volume":"50","author":"CD Funk","year":"2007","unstructured":"Funk CD, FitzGerald GA. COX-2 inhibitors and cardiovascular risk. J Cardiovasc Pharmacol. 2007;50(5):470\u20139.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"2427_CR49","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/joim.13505","volume":"292","author":"C-O Stiller","year":"2022","unstructured":"Stiller C-O, Hjemdahl P. Lessons from 20 years with COX-2 inhibitors: importance of dose\u2013response considerations and fair play in comparative trials. J Intern Med. 2022;292(4):557\u201374.","journal-title":"J Intern Med"},{"issue":"12","key":"2427_CR50","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"MR Paul","year":"2017","unstructured":"Paul MR, Brendan ME, Tom T, Jean GM, William HC, Christie B, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"key":"2427_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212425","author":"EV Gerasimova","year":"2024","unstructured":"Gerasimova EV, Popkova TV, Kirillova IG, Gerasimova DA, Nasonov EL, Lila AM. Interleukin-6: cardiovascular aspects of long-term cytokine suppression in patients with rheumatoid arthritis. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252212425.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2427_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70048","volume":"24","author":"B Csik","year":"2025","unstructured":"Csik B, Ny\u00fal-T\u00f3th \u00c1, Gulej R, Patai R, Kiss T, Delfavero J, et al. Senescent endothelial cells in cerebral microcirculation are key drivers of age-related blood-brain barrier disruption, microvascular rarefaction, and neurovascular coupling impairment in mice. Aging Cell. 2025;24(7):e70048.","journal-title":"Aging Cell"},{"issue":"5","key":"2427_CR53","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1007\/s11357-021-00440-z","volume":"43","author":"S Tarantini","year":"2021","unstructured":"Tarantini S, Balasubramanian P, Delfavero J, Csipo T, Yabluchanskiy A, Kiss T, et al. Treatment with the BCL-2\/BCL-xL inhibitor senolytic drug ABT263\/Navitoclax improves functional hyperemia in aged mice. Geroscience. 2021;43(5):2427\u201340.","journal-title":"Geroscience"},{"issue":"15","key":"2427_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157155","volume":"26","author":"C Cianciarulo","year":"2025","unstructured":"Cianciarulo C, Nguyen TH, Zacharias A, Standen N, Tucci J, Irving H. Analysis of phosphodiesterase-5 (PDE5) inhibitors in modulating inflammatory markers in humans: a systematic review and meta-analysis. Int J Mol Sci. 2025;26(15):7155.","journal-title":"Int J Mol Sci"},{"key":"2427_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2026.104035","author":"A Bazs\u00f3","year":"2026","unstructured":"Bazs\u00f3 A, Szodoray P, Shoenfeld Y, Nagy G, Kiss E. Targeting autoimmunity: phosphodiesterase inhibitors as immunomodulators\u2014a review of current insights and future direction. Autoimmun Rev. 2026. https:\/\/doi.org\/10.1016\/j.autrev.2026.104035.","journal-title":"Autoimmun Rev"},{"key":"2427_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd9010004","author":"M Lorigo","year":"2021","unstructured":"Lorigo M, Oliveira N, Cairrao E. PDE-mediated cyclic nucleotide compartmentation in vascular smooth muscle cells: from basic to a clinical perspective. J Cardiovasc Dev Dis. 2021. https:\/\/doi.org\/10.3390\/jcdd9010004.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"2","key":"2427_CR57","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1210\/er.2013-1053","volume":"35","author":"MF Azevedo","year":"2014","unstructured":"Azevedo MF, Faucz FR, Bimpaki E, Horvath A, Levy I, de Alexandre RB, et al. Clinical and molecular genetics of the phosphodiesterases (PDEs). Endocr Rev. 2014;35(2):195\u2013233.","journal-title":"Endocr Rev"},{"issue":"1","key":"2427_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-023-00423-2","volume":"28","author":"A Janaszak-Jasiecka","year":"2023","unstructured":"Janaszak-Jasiecka A, P\u0142oska A, Wiero\u0144ska JM, Dobrucki LW, Kalinowski L. Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets. Cell Mol Biol Lett. 2023;28(1):21.","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"2427_CR59","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","volume":"124","author":"M Guazzi","year":"2011","unstructured":"Guazzi M, Vicenzi M, Arena R, Guazzi MD. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation. 2011;124(2):164\u201374.","journal-title":"Circulation"},{"issue":"14","key":"2427_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cells12141903","volume":"12","author":"EH Mace","year":"2023","unstructured":"Mace EH, Kimlinger MJ, Billings FT, Lopez MG. Targeting soluble guanylyl cyclase during ischemia and reperfusion. Cells. 2023;12(14):1903.","journal-title":"Cells"},{"issue":"2","key":"2427_CR61","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1152\/japplphysiol.00728.2004","volume":"98","author":"DL Kellogg","year":"2005","unstructured":"Kellogg DL, Zhao JL, Coey U, Green JV. Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin. J Appl Physiol. 2005;98(2):629\u201332.","journal-title":"J Appl Physiol"},{"issue":"3","key":"2427_CR62","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/FJC.0b013e3181eb4e75","volume":"56","author":"FBM Priviero","year":"2010","unstructured":"Priviero FBM, Webb RC. Heme-dependent and independent soluble guanylate cyclase activators and vasodilation. J Cardiovasc Pharmacol. 2010;56(3):229\u201333.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"21","key":"2427_CR63","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1111\/bph.15698","volume":"181","author":"P Sandner","year":"2024","unstructured":"Sandner P, Follmann M, Becker\u2010Pelster E, Hahn MG, Meier C, Freitas C, et al. Soluble GC stimulators and activators: past, present and future. Br J Pharmacol. 2024;181(21):4130\u201351.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"2427_CR64","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1161\/CIRCRESAHA.117.303776","volume":"120","author":"JR Kraehling","year":"2017","unstructured":"Kraehling JR, Sessa WC. Contemporary approaches to modulating the nitric oxide\u2013cGMP pathway in cardiovascular disease. Circ Res. 2017;120(7):1174\u201382.","journal-title":"Circ Res"},{"issue":"2","key":"2427_CR65","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1124\/jpet.107.128009","volume":"325","author":"P Wohlfart","year":"2008","unstructured":"Wohlfart P, Xu H, Endlich A, Habermeier A, Closs EI, H\u00fcbschle T, et al. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling. J Pharmacol Exp Ther. 2008;325(2):370\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2427_CR66","doi-asserted-by":"publisher","first-page":"46","DOI":"10.14336\/AD.2022.0523","volume":"14","author":"Z Cai","year":"2023","unstructured":"Cai Z, Wu C, Xu Y, Cai J, Zhao M, Zu L. The NO-cGMP-PKG axis in HFpEF: from pathological mechanisms to potential therapies. Aging Dis. 2023;14(1):46\u201362.","journal-title":"Aging Dis"},{"issue":"7","key":"2427_CR67","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1161\/CIRCRESAHA.118.311378","volume":"123","author":"Z Ungvari","year":"2018","unstructured":"Ungvari Z, Tarantini S, Donato AJ, Galvan V, Csiszar A. Mechanisms of vascular aging. Circ Res. 2018;123(7):849\u201367.","journal-title":"Circ Res"},{"issue":"1","key":"2427_CR68","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/apha.12649","volume":"219","author":"CJ Garland","year":"2017","unstructured":"Garland CJ, Dora KA. EDH: endothelium-dependent hyperpolarization and microvascular signalling. Acta Physiol (Oxf). 2017;219(1):152\u201361.","journal-title":"Acta Physiol (Oxf)"},{"issue":"12","key":"2427_CR69","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1042\/CS20140753","volume":"129","author":"PK Bautista Ni\u00f1o","year":"2015","unstructured":"Bautista Ni\u00f1o PK, Durik M, Danser AH, de Vries R, Musterd-Bhaggoe UM, Meima ME, et al. Phosphodiesterase 1 regulation is a key mechanism in vascular aging. Clin Sci (Lond). 2015;129(12):1061\u201375.","journal-title":"Clin Sci (Lond)"},{"issue":"8","key":"2427_CR70","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/RHU.0000000000000432","volume":"22","author":"FM Ding","year":"2016","unstructured":"Ding FM, Li M, Yang X, Ye Y, Kang L, Pang H, et al. Accelerated age-related arterial stiffness in systemic lupus erythematosus patients. J Clin Rheumatol. 2016;22(8):426\u201333.","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"2427_CR71","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0735-1097(10)80218-9","volume":"18","author":"H Kazuhito","year":"1991","unstructured":"Kazuhito H, Filippos T, Elizabeth S, Juan B, Charles FW, Harisios B. The Marfan syndrome: abnormal aortic elastic properties. Jacc. 1991;18(1):57\u201363.","journal-title":"Jacc"},{"issue":"3","key":"2427_CR72","doi-asserted-by":"publisher","first-page":"1005322","DOI":"10.3389\/fragi.2022.1005322","volume":"12","author":"MB Birkisd\u00f3ttir","year":"2022","unstructured":"Birkisd\u00f3ttir MB, van Galen I, Brandt RM, Barnhoorn S, van Vliet N, van Dijk C, Nagarajah B, Imholz S, van Oostrom CT, Reiling E, Gyenis \u00c1. The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside. Frontiers in Aging. 2022;12(3):1005322.","journal-title":"Frontiers in Aging."}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02427-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02427-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02427-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:03:45Z","timestamp":1785801825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02427-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":72,"alternative-id":["2427"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02427-0","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}